These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27999070)

  • 21. Understanding the Influence of Socioeconomic Environment on Paediatric Antiretroviral Treatment Coverage: Towards Closing Treatment Gaps in Sub-Saharan Africa.
    Adeyinka DA; Evans MR; Ozigbu CE; van Woerden H; Adeyinka EF; Oladimeji O; Aimakhu C; Odoh D; Chamla D
    Cent Eur J Public Health; 2017 Mar; 25(1):55-63. PubMed ID: 28399356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Male partners' involvement in prevention of mother-to-child HIV transmission in sub-Saharan Africa: A systematic review.
    Manjate Cuco RM; Munguambe K; Bique Osman N; Degomme O; Temmerman M; Sidat MM
    SAHARA J; 2015; 12():87-105. PubMed ID: 26726756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and predictors of virological failure in pediatric patients on HAART in sub-Saharan Africa: a systematic review and meta-analysis.
    Machila N; Libonda L; Habineza P; Velu RM; Kamboyi HK; Ndhlovu J; Wamunyima I; Sinadambwe MM; Mudenda S; Zyambo C; Bumbangi FN
    Pan Afr Med J; 2023; 45():98. PubMed ID: 37692980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance at virological failure using boosted protease inhibitors versus nonnucleoside reverse transcriptase inhibitors as first-line antiretroviral therapy--implications for sustained efficacy of ART in resource-limited settings.
    Hill A; McBride A; Sawyer AW; Clumeck N; Gupta RK
    J Infect Dis; 2013 Jun; 207 Suppl 2():S78-84. PubMed ID: 23687293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.
    Arrivé E; Newell ML; Ekouevi DK; Chaix ML; Thiebaut R; Masquelier B; Leroy V; Perre PV; Rouzioux C; Dabis F;
    Int J Epidemiol; 2007 Oct; 36(5):1009-21. PubMed ID: 17533166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Missing HIV prevention opportunities in South African children--a 7-year review.
    Feucht UD; Meyer A; Kruger M
    BMC Public Health; 2014 Dec; 14():1265. PubMed ID: 25495201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.
    Amani-Bosse C; Dahourou DL; Malateste K; Amorissani-Folquet M; Coulibaly M; Dattez S; Emieme A; Barry M; Rouzioux C; N'gbeche S; Yonaba C; Timité-Konan M; Mea V; Ouédraogo S; Blanche S; Meda N; Seguin-Devaux C; Leroy V
    J Int AIDS Soc; 2017 Apr; 20(1):21362. PubMed ID: 28453240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali.
    Crowell CS; Maiga AI; Sylla M; Taiwo B; Kone N; Oron AP; Murphy RL; Marcelin AG; Traore B; Fofana DB; Peytavin G; Chadwick EG
    Pediatr Infect Dis J; 2017 Nov; 36(11):e258-e263. PubMed ID: 28198788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of interventions to improve prevention of mother-to-child HIV transmission service delivery and promote retention.
    Ambia J; Mandala J
    J Int AIDS Soc; 2016; 19(1):20309. PubMed ID: 27056361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequencing paediatric antiretroviral therapy in the context of a public health approach.
    Boerma RS; Boender TS; van Hensbroek MB; Rinke de Wit TF; Sigaloff KC
    J Int AIDS Soc; 2015; 18(Suppl 6):20265. PubMed ID: 26639116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey.
    Tchouwa GF; Eymard-Duvernay S; Cournil A; Lamare N; Serrano L; Butel C; Bertagnolio S; Mpoudi-Ngole E; Raizes E; Aghokeng AF;
    J Antimicrob Chemother; 2018 Sep; 73(9):2468-2474. PubMed ID: 29931063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Rates of Drug Resistance Among Newly Diagnosed HIV-infected Children in the National Prevention of Mother-to-child Transmission Program in Togo.
    Salou M; Butel C; Konou AA; Ekouevi DK; Vidal N; Dossim S; Lawson-Evi K; Nyasenu YT; Singo-Tokofaï A; d'Almeida S; Tchama R; Delaporte E; Prince-David M; Peeters M; Dagnra AY
    Pediatr Infect Dis J; 2016 Aug; 35(8):879-85. PubMed ID: 27167115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of mother-to-child transmission of HIV in rural Uganda: modelling effectiveness and impact of scaling-up PMTCT services.
    Larsson EC; Ekström AM; Pariyo G; Tomson G; Sarowar M; Baluka R; Galiwango E; Thorson AE
    Glob Health Action; 2015; 8():26308. PubMed ID: 25726836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model.
    Westreich D; Eron J; Behets F; Horst Cv; Van Rie A
    J Infect Dis; 2007 Mar; 195(6):837-46. PubMed ID: 17299714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 drug resistance surveillance in antiretroviral treatment-naive individuals from a reference hospital in Guatemala, 2010-2013.
    Avila-Ríos S; García-Morales C; Garrido-Rodríguez D; Tapia-Trejo D; Girón-Callejas AC; Mendizábal-Burastero R; Escobar-Urias IY; García-González BL; Navas-Castillo S; Pinzón-Meza R; Mejía-Villatoro CR; Reyes-Terán G
    AIDS Res Hum Retroviruses; 2015 Apr; 31(4):401-11. PubMed ID: 25347163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Prevalence of HIV Low Abundance Drug-Resistant Variants in a Treatment-Naive Population in North Rift Kenya.
    Cheriro W; Kiptoo M; Kikuvi G; Mining S; Emonyi W; Songok E
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1274-7. PubMed ID: 26414430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The burden of vaccine-preventable diseases among HIV-infected and HIV-exposed children in sub-Saharan Africa: a systematic review and meta-analysis.
    Adetokunboh OO; Awotiwon A; Ndwandwe D; Uthman OA; Wiysonge CS
    Hum Vaccin Immunother; 2019; 15(11):2590-2605. PubMed ID: 30945963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends of prevalence of primary HIV drug resistance in Germany.
    Sagir A; Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Schmutz G; Hower M; Emmelkamp J; Pfister H; Häussinger D;
    J Antimicrob Chemother; 2007 Oct; 60(4):843-8. PubMed ID: 17715124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of rilpivirine resistance in people starting antiretroviral treatment in Argentina.
    Bissio E; Barbás MG; Kademián S; Bouzas MB; Salomón H; Cudolá A; Giuliano SF; Falistocco C
    Antivir Ther; 2017; 22(7):625-629. PubMed ID: 28234630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.